Geovax Labs Inc

Research Geovax Labs Inc (GOVX) on Bullrun: market cap USD 3.61M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGOVX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.61M
• Financial periodFY2025
• RevenueUSD 2.49M
• Revenue growth-37.1%
• Net income-USD 21.46M
• Free cash flow-USD 21.50M

Valuation Snapshot

latest market cap is USD 3.61M.

About Geovax Labs Inc

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma;

Frequently asked questions

What is Geovax Labs Inc's market cap?

Geovax Labs Inc's market capitalization is USD 3.61M.

What does Geovax Labs Inc do?

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.